KCNN4
The protein encoded by this gene is part of a potentially heterotetrameric voltage-independent potassium channel that is activated by intracellular calcium. Activation is followed by membrane hyperpolarization, which promotes calcium influx. The encoded protein may be part of the predominant calcium-activated potassium channel in T-lymphocytes. This gene is similar to other KCNN family potassium channel genes, but it differs enough to possibly be considered as part of a new subfamily.
                Full Name
                    potassium calcium-activated channel subfamily N member 4
                Function
                    Forms a voltage-independent potassium channel that is activated by intracellular calcium (PubMed:26148990).
Activation is followed by membrane hyperpolarization which promotes calcium influx. Required for maximal calcium influx and proliferation during the reactivation of naive T-cells (PubMed:17157250, PubMed:18796614).
Plays a role in the late stages of EGF-induced macropinocytosis (PubMed:24591580).
                Activation is followed by membrane hyperpolarization which promotes calcium influx. Required for maximal calcium influx and proliferation during the reactivation of naive T-cells (PubMed:17157250, PubMed:18796614).
Plays a role in the late stages of EGF-induced macropinocytosis (PubMed:24591580).
Biological Process
                    Calcium ion transportManual Assertion Based On ExperimentIDA:BHF-UCL
Cell volume homeostasisIEA:Ensembl
Defense responseManual Assertion Based On ExperimentTAS:ProtInc
Immune system processIEA:UniProtKB-KW
Ion transportManual Assertion Based On ExperimentIBA:GO_Central
Phospholipid translocationIEA:Ensembl
Positive regulation of potassium ion transmembrane transportTAS:Reactome
Positive regulation of protein secretionIEA:Ensembl
Positive regulation of T cell receptor signaling pathwayManual Assertion Based On ExperimentIDA:BHF-UCL
Potassium ion transmembrane transportManual Assertion Based On ExperimentIBA:GO_Central
Potassium ion transportManual Assertion Based On ExperimentTAS:ProtInc
Saliva secretionIEA:Ensembl
Stabilization of membrane potentialManual Assertion Based On ExperimentIDA:BHF-UCL
                Cell volume homeostasisIEA:Ensembl
Defense responseManual Assertion Based On ExperimentTAS:ProtInc
Immune system processIEA:UniProtKB-KW
Ion transportManual Assertion Based On ExperimentIBA:GO_Central
Phospholipid translocationIEA:Ensembl
Positive regulation of potassium ion transmembrane transportTAS:Reactome
Positive regulation of protein secretionIEA:Ensembl
Positive regulation of T cell receptor signaling pathwayManual Assertion Based On ExperimentIDA:BHF-UCL
Potassium ion transmembrane transportManual Assertion Based On ExperimentIBA:GO_Central
Potassium ion transportManual Assertion Based On ExperimentTAS:ProtInc
Saliva secretionIEA:Ensembl
Stabilization of membrane potentialManual Assertion Based On ExperimentIDA:BHF-UCL
Cellular Location
                    Cell membrane
                Involvement in disease
                    Dehydrated hereditary stomatocytosis 2 (DHS2):
An autosomal dominant hemolytic anemia characterized by primary erythrocyte dehydration. Erythrocytes exhibit decreased total cation and potassium content that are not accompanied by a proportional net gain of sodium and water. Affected individuals typically manifest mild to moderate compensated hemolytic anemia, with an increased erythrocyte mean corpuscular hemoglobin concentration and a decreased osmotic fragility, both of which reflect cellular dehydration. Their red cells exhibit a panel of various shape abnormalities such as elliptocytes, hemighosts, schizocytes, and very rare stomatocytic cells. Complications such as splenomegaly and cholelithiasis, resulting from increased red cell trapping in the spleen and elevated bilirubin levels, respectively, may occur.
                An autosomal dominant hemolytic anemia characterized by primary erythrocyte dehydration. Erythrocytes exhibit decreased total cation and potassium content that are not accompanied by a proportional net gain of sodium and water. Affected individuals typically manifest mild to moderate compensated hemolytic anemia, with an increased erythrocyte mean corpuscular hemoglobin concentration and a decreased osmotic fragility, both of which reflect cellular dehydration. Their red cells exhibit a panel of various shape abnormalities such as elliptocytes, hemighosts, schizocytes, and very rare stomatocytic cells. Complications such as splenomegaly and cholelithiasis, resulting from increased red cell trapping in the spleen and elevated bilirubin levels, respectively, may occur.
PTM
                    Phosphorylation at His-358 by NDKB activates the channel, and conversely it's dephosphorylation by PHPT1 inhibits the channel.
                
                            View more
                        
   
                    Anti-KCNN4 antibodies
 + Filters
		 Loading...
Loading...
        Target: KCNN4
                
                Host: Mouse
                
                Antibody Isotype: IgG2a
                
                Specificity: Human, Mouse, Rat
                
                Clone: A742
                
                Application*: ELISA, WB
                
            Target: KCNN4
                
                Host: Mouse
                
                Antibody Isotype: IgG1
                
                Specificity: Human
                
                Clone: CBT3141
                
                Application*: WB, IC, F
                
            Target: KCNN4
                
                Host: Mouse
                
                Antibody Isotype: IgG1
                
                Specificity: Human
                
                Clone: CBT2056
                
                Application*: WB, F
                
            Target: KCNN4
                
                Host: Rabbit
                
                Antibody Isotype: IgG
                
                Specificity: Human, Mouse, Rat
                
                Clone: EG1769
                
                Application*: WB: 1:500~1:1000 ELISA: 1:5000
                
            Target: KCNN4
                
                Host: Mouse
                
                Antibody Isotype: IgG2a
                
                Specificity: Human, Mouse, Rat
                
                Clone: CF254
                
                Application*: ELISA, WB
                
            More Infomation
Hot products 
    - 
            Mouse Anti-8-oxoguanine Recombinant Antibody (V2-7697) (CBMAB-1869CQ)  
- 
            Mouse Anti-ARID1B Recombinant Antibody (KMN1) (CBMAB-A3546-YC)  
- 
            Mouse Anti-DHFR Recombinant Antibody (D0821) (CBMAB-D0821-YC)  
- 
            Mouse Anti-ATP5F1A Recombinant Antibody (51) (CBMAB-A4043-YC)  
- 
            Mouse Anti-AHCYL1 Recombinant Antibody (V2-180270) (CBMAB-A1703-YC)  
- 
            Mouse Anti-ATG5 Recombinant Antibody (9H197) (CBMAB-A3945-YC)  
- 
            Mouse Anti-CAT Recombinant Antibody (724810) (CBMAB-C8431-LY)  
- 
            Mouse Anti-CASQ1 Recombinant Antibody (CBFYC-0863) (CBMAB-C0918-FY)  
- 
            Mouse Anti-CD46 Recombinant Antibody (CBFYC-0076) (CBMAB-C0085-FY)  
- 
            Mouse Anti-DMPK Recombinant Antibody (CBYCD-324) (CBMAB-D1200-YC)  
- 
            Mouse Anti-ACTN4 Recombinant Antibody (V2-6075) (CBMAB-0020CQ)  
- 
            Mouse Anti-ANXA7 Recombinant Antibody (A-1) (CBMAB-A2941-YC)  
- 
            Mouse Anti-C5b-9 Recombinant Antibody (aE11) (CBMAB-AO138LY)  
- 
            Mouse Anti-BANF1 Recombinant Antibody (3F10-4G12) (CBMAB-A0707-LY)  
- 
            Mouse Anti-ATP1B3 Recombinant Antibody (1E9) (CBMAB-A4021-YC)  
- 
            Mouse Anti-CRTAM Recombinant Antibody (CBFYC-2235) (CBMAB-C2305-FY)  
- 
            Mouse Anti-ACTG1 Recombinant Antibody (V2-179597) (CBMAB-A0916-YC)  
- 
            Mouse Anti-DLL4 Recombinant Antibody (D1090) (CBMAB-D1090-YC)  
- 
            Mouse Anti-AAV-5 Recombinant Antibody (V2-503416) (CBMAB-V208-1402-FY)  
- 
            Mouse Anti-ALPL Antibody (B4-78) (CBMAB-1009CQ)  
For Research Use Only. Not For Clinical Use.
                    (P): Predicted
* Abbreviations 
- AActivation
- AGAgonist
- APApoptosis
- BBlocking
- BABioassay
- BIBioimaging
- CImmunohistochemistry-Frozen Sections
- CIChromatin Immunoprecipitation
- CTCytotoxicity
- CSCostimulation
- DDepletion
- DBDot Blot
- EELISA
- ECELISA(Cap)
- EDELISA(Det)
- ESELISpot
- EMElectron Microscopy
- FFlow Cytometry
- FNFunction Assay
- GSGel Supershift
- IInhibition
- IAEnzyme Immunoassay
- ICImmunocytochemistry
- IDImmunodiffusion
- IEImmunoelectrophoresis
- IFImmunofluorescence
- IGImmunochromatography
- IHImmunohistochemistry
- IMImmunomicroscopy
- IOImmunoassay
- IPImmunoprecipitation
- ISIntracellular Staining for Flow Cytometry
- LALuminex Assay
- LFLateral Flow Immunoassay
- MMicroarray
- MCMass Cytometry/CyTOF
- MDMeDIP
- MSElectrophoretic Mobility Shift Assay
- NNeutralization
- PImmunohistologyp-Paraffin Sections
- PAPeptide Array
- PEPeptide ELISA
- PLProximity Ligation Assay
- RRadioimmunoassay
- SStimulation
- SESandwich ELISA
- SHIn situ hybridization
- TCTissue Culture
- WBWestern Blot
 
                Online Inquiry
                
    
           
        
 Compare
Compare 
        


